🇺🇸 iSGLT2 in United States
2 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 2
Most-reported reactions
- Escherichia Urinary Tract Infection — 1 report (50%)
- Urosepsis — 1 report (50%)
Frequently asked questions
Is iSGLT2 approved in United States?
iSGLT2 does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for iSGLT2 in United States?
Maximo Agustin Schiavone is the originator. The local marketing authorisation holder may differ — check the official source linked above.